药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Brompheniramine
Temsirolimus
The serum concentration of Temsirolimus can be increased when it is combined with Budesonide.
Brompheniramine
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Budesonide.
Brompheniramine
Lopinavir
The serum concentration of Budesonide can be increased when it is combined with Lopinavir.
Brompheniramine
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Budesonide.
Brompheniramine
Rimegepant
The metabolism of Rimegepant can be increased when combined with Budesonide.
Brompheniramine
Fosphenytoin
The serum concentration of Fosphenytoin can be decreased when it is combined with Budesonide.
Brompheniramine
Lumateperone
The serum concentration of Lumateperone can be decreased when it is combined with Budesonide.
Brompheniramine
Lemborexant
The serum concentration of Lemborexant can be decreased when it is combined with Budesonide.
Brompheniramine
Ephedrine
Ephedrine may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Brompheniramine
Niperotidine
Niperotidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Lavoltidine
Lavoltidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Lafutidine
Lafutidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Roxatidine acetate
Roxatidine acetate can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Metiamide
Metiamide can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Asenapine
Asenapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Methantheline
Methantheline can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Ilaprazole
Ilaprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Dexrabeprazole
Dexrabeprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Brompheniramine
Cenobamate
The serum concentration of Budesonide can be decreased when it is combined with Cenobamate.